The causes, treatment, and outcome of pulmonary hypertension in Africa: Insights from the Pan African Pulmonary Hypertension Cohort (PAPUCO) Registry

International Journal of Cardiology

Volumn 221, Issue , 2016, Pages 205-211

  Thienemann, Friedrich ^a   Dzudie, Anastase ^b   Mocumbi, Ana O ^c   Blauwet, Lori ^d   Sani, Mahmoud U ^e   Karaye, Kamilu M ^e   Ogah, Okechukwu S ^f   Mbanze, Irina ^c   Mbakwem, Amam ^g   Udo, Patience ^h   Tibazarwa, Kemi ^a,i   Damasceno, Albertino ^c   Keates, Ashley K ^j   Stewart, Simon ^a,j,k   Sliwa, Karen ^a,k  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b Douala General Hospital and Buea University   (Cameroon)

^c EDUARDO MONDLANE UNIVERSITY   (Mozambique)

^d MAYO CLINIC   (United States)

^e AMINU KANO TEACHING HOSPITAL   (Nigeria)

^f UNIVERSITY OF IBADAN   (Nigeria)

^g UNIVERSITY OF LAGOS   (Nigeria)

^h UNIVERSITY OF UYO   (Nigeria)

ⁱ MUHIMBILI NATIONAL HOSPITAL   (Tanzania)

^j AUSTRALIAN CATHOLIC UNIVERSITY   (Australia)

^k UNIVERSITY OF THE WITWATERSRAND   (South Africa)

more..

Author keywords

Africa; Congenital heart disease; HIV; Pulmonary hypertension; Registries

Indexed keywords

AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; PHOSPHODIESTERASE V INHIBITOR; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CAMEROON; CHILD; CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION; COHORT ANALYSIS; CONGENITAL HEART DISEASE; COUGHING; DISEASE REGISTRY; DYSPNEA; FATIGUE; FEMALE; FOLLOW UP; FUNCTIONAL DISEASE; HEART ATRIUM ENLARGEMENT; HEART DISEASE; HEART PALPITATION; HEART RIGHT VENTRICLE HYPERTROPHY; HEART RIGHT VENTRICLE PRESSURE; HUMAN; HYPERTENSION; HYPOXIA; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MOZAMBIQUE; NIGERIA; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; RIGHT VENTRICULAR SYSTOLIC PRESSURE; SOUTH AFRICA; AFRICA; COMPLICATION; FAMILIAL PRIMARY PULMONARY HYPERTENSION; HEART DEFECTS, CONGENITAL; HEART RIGHT VENTRICLE FUNCTION; HYPERTENSION, PULMONARY; INFANT; KAPLAN MEIER METHOD; MIDDLE AGED; PHYSIOLOGY;

ADOLESCENT; AFRICA; CHILD; FAMILIAL PRIMARY PULMONARY HYPERTENSION; HEART DEFECTS, CONGENITAL; HUMANS; HYPERTENSION, PULMONARY; INFANT; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; VENTRICULAR FUNCTION, RIGHT;

EID: 84978488616     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2016.06.242     Document Type: Article

References (25)

1. [1] Simonneau, G., Gatzoulis, M.A., Adatia, I., et al. Updated clinical classification of pulmonary hypertension. J. Am. Coll. Cardiol. 62:25 Suppl. (2013), D34–D41.
2. [2] Sliwa, K., Wilkinson, D., Hansen, C., et al. Spectrum of heart disease and risk factors in a black urban population in South Africa (the Heart of Soweto Study): a cohort study. Lancet 371:9616 (2008), 915–922.
3. [3] Stewart, S., Mocumbi, A.O., Carrington, M.J., Pretorius, S., Burton, R., Sliwa, K., A not-so-rare form of heart failure in urban black Africans: pathways to right heart failure in the Heart of Soweto Study cohort. Eur. J. Heart Fail. 13:10 (2011), 1070–1077.
4. [4] Mocumbi, A.O., Thienemann, F., Sliwa, K., A global perspective on the epidemiology of pulmonary hypertension. Can. J. Cardiol. 31:4 (2015), 375–381.
5. [5] Sliwa, K., Carrington, M.J., Becker, A., Thienemann, F., Ntsekhe, M., Stewart, S., Contribution of the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic to de novo presentations of heart disease in the Heart of Soweto Study cohort. Eur. Heart J. 33:7 (2012), 866–874.
6. [6] Mocumbi, A.O., Lameira, E., Yaksh, A., Paul, L., Ferreira, M.B., Sidi, D., Challenges on the management of congenital heart disease in developing countries. Int. J. Cardiol. 148:3 (2011), 285–288.
7. [7] Sliwa, K., Mocumbi, A.O., Forgotten cardiovascular diseases in Africa. Clin. Res. Cardiol. 99:2 (2010), 65–74.
8. [8] Sliwa, K., Carrington, M., Mayosi, B.M., Zigiriadis, E., Mvungi, R., Stewart, S., Incidence and characteristics of newly diagnosed rheumatic heart disease in urban African adults: insights from the heart of Soweto study. Eur. Heart J. 31:6 (2010), 719–727.
9. [9] Ogah, O.S., Sliwa, K., Akinyemi, J.O., Falase, A.O., Stewart, S., Hypertensive heart failure in Nigerian Africans: insights from the Abeokuta Heart Failure Registry. J. Clin. Hypertens. 17:4 (2015), 263–272.
10. [10] Stewart, S., Wilkinson, D., Hansen, C., et al. Predominance of heart failure in the Heart of Soweto Study cohort: emerging challenges for urban African communities. Circulation 118:23 (2008), 2360–2367.
11. [11] Thienemann, F., Dzudie, A., Mocumbi, A.O., et al. Rationale and design of the Pan African Pulmonary hypertension Cohort (PAPUCO) study: implementing a contemporary registry on pulmonary hypertension in Africa. BMJ Open, 4(10), 2014, e005950.
12. [12] von Elm, E., Altman, D.G., Egger, M., et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370:9596 (2007), 1453–1457.
13. [13] Galie, N., Hoeper, M.M., Humbert, M., et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Eur. Heart J., 2016, 67–119.
14. [14] Ahmed, A.E., Ibrahim, A.S., Elshafie, S.M., Pulmonary hypertension in patients with treated pulmonary tuberculosis: analysis of 14 consecutive cases. Clin. Med. Insights Circ. Respir. Pulm. Med. 5 (2011), 1–5.
15. [15] Cox, H., Hughes, J., Daniels, J., et al. Community-based treatment of drug-resistant tuberculosis in Khayelitsha, South Africa. Int. J. Tuberc. Lung Dis. 18:4 (2014), 441–448.
16. [16] McGoon, M.D., Krichman, A., Farber, H.W., et al. Design of the REVEAL registry for US patients with pulmonary arterial hypertension. Mayo Clin. Proc. 83:8 (2008), 923–931.
17. [17] Olsson, K.M., Delcroix, M., Ghofrani, H.A., et al. Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA). Circulation 129:1 (2014), 57–65.
18. [18] Humbert, M., Sitbon, O., Chaouat, A., et al. Pulmonary arterial hypertension in France: results from a national registry. Am. J. Respir. Crit. Care Med. 173:9 (2006), 1023–1030.
19. [19] Hoeper, M.M., Huscher, D., Ghofrani, H.A., et al. Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry. Int. J. Cardiol. 168:2 (2013), 871–880.
20. [20] Strange, G., Playford, D., Stewart, S., et al. Pulmonary hypertension: prevalence and mortality in the Armadale echocardiography cohort. Heart 98:24 (2012), 1805–1811.
21. [21] Enea, I., Ghio, S., Bongarzoni, A., et al. Echocardiographic alterations suggestive of pulmonary hypertension in the Italian ultrasonography laboratories. Epidemiological data from the INCIPIT study (INCidence of Pulmonary Hypertension in Italian ulTrasonography laboratories). G. Ital. Cardiol. 11:5 (2010), 402–407.
22. [22] Damasceno, A., Mayosi, B.M., Sani, M., et al. The causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries. Arch. Intern. Med. 172:18 (2012), 1386–1394.
23. [23] Engel, M.E., Haileamlak, A., Zuhlke, L., et al. Prevalence of rheumatic heart disease in 4720 asymptomatic scholars from South Africa and Ethiopia. Heart 101:17 (2015), 1389–1394.
24. [24] Graham, B.B., Bandeira, A.P., Morrell, N.W., Butrous, G., Tuder, R.M., Schistosomiasis-associated pulmonary hypertension: pulmonary vascular disease: the global perspective. Chest 137:6 Suppl. (2010), 20S–29S.
25. [25] McMurray, J.J., Adamopoulos, S., Anker, S.D., et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur. J. Heart Fail. 14:8 (2012), 803–869.